E
Live / Registered — Cancelled — Section 71 (as of 30 May 2025)
What this means for you
Registered since 13 Nov 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79208607
- Registration number
- 5603613
- Mark type
- Design + words
- Filed
- 15 Dec 2016
- Published for opposition
- 28 Aug 2018
- Registered
- 13 Nov 2018
- Attorney of record
- Susan Piasick Christoff
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents in the form of exosomes that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for transport of therapeutic agents; pharmaceutical preparations, namely, engineered exosomes that deliver protein for genetic therapy; biological preparations comprising exosome for medical use; biological reagents comprising exosome for medical use; mixed biological preparations comprising exosome for pharmaceutical and medical use; diagnostic reagents comprising exosome for medicinal use in the fields of biology, genetic engineering and pharmaceuticals; pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, extracellular vesicle-based nucleic acid therapeutics for the prevention and treatment of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in the detection of infectious diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, mitochondrial disease, neuromuscular disease, inflammatory diseases and autoimmune disorders
- Class 042 — Scientific and technological services: Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; biological research; clinical research in the field of transformational therapeutics; providing medical and scientific research information in the field of filtration of exosomes from blood; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of infectious diseases and metabolic disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science
Owner
Prosecution history
- 30 Jan 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 May 2025 — CANCELLED SECTION 71
- 13 Nov 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 04 Dec 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 30 Jul 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Mar 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Feb 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Feb 2019 — FINAL DISPOSITION PROCESSED
- 13 Feb 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 13 Nov 2018 — REGISTERED-PRINCIPAL REGISTER
- 28 Aug 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Aug 2018 — PUBLISHED FOR OPPOSITION
- 24 Aug 2018 — NOTIFICATION PROCESSED BY IB
- 08 Aug 2018 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Aug 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED